Literature DB >> 7731139

Developmental expression of renal angiotensin II receptor genes in the mouse.

J Kakuchi1, T Ichiki, S Kiyama, B L Hogan, A Fogo, T Inagami, I Ichikawa.   

Abstract

The cellular distribution of angiotensin II type 1 (AT1) and type 2 (AT2) receptor mRNA was examined in mouse kidneys at several embryonic stages (12 to 18 days; 19 days = full term) and up to three weeks after birth by in situ hybridization. The expression of both AT1 and AT2 mRNAs appeared simultaneously at 14 days of gestation. However, their distributions were contrasting: AT1 mRNA was expressed in mature glomeruli and maturing S-shaped bodies throughout the stages examined. AT1 expression was also detected at 16 days of gestation in the proximal and distal tubules and peaked at the end of gestation. Both the temporal and spatial expression of AT1 coincide with the differentiation and proliferation of glomerular mesangial and tubular cells during nephrogenesis. In contrast, AT2 mRNA was present only in the mesenchymal cells adjacent to the stalk of the ureter bud at early developmental stages, and, later, extended to the mesenchymal cells located near, but outside, the nephrogenic area of superficial cortex and also the cells between collecting ducts. AT2 expression in these regions decreased markedly within three weeks after birth. Temporally and spatially, AT2 mRNA expression coincides with the epithelial-mesenchymal interactions that take place during early phases of nephrogenesis. The site of AT2 expression also overlaps closely with that of a specific group of cells which undergo apoptosis following nephrogenesis. Thus, contrary to current belief, the activation of AT1 and AT2 genes takes place in different cell types of the kidney during embryonic development, and thereby conceivably contributes to the ontogeny of those specific renal cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731139     DOI: 10.1038/ki.1995.16

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  Angiotensin II regulates growth of the developing papillas ex vivo.

Authors:  Renfang Song; Graeme Preston; Ali Khalili; Samir S El-Dahr; Ihor V Yosypiv
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  No evidence for angiotensin type 2 receptor gene polymorphism in intron 1 in patients with coarctation of the aorta and Ullrich-Turner syndrome.

Authors:  E Struwe; K Krammer; J Dötsch; M Metzler; H G Dörr; R Cesnjevar; W Rascher; A Koch
Journal:  Pediatr Cardiol       Date:  2006-08-30       Impact factor: 1.655

4.  Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.

Authors:  M I Oliverio; H S Kim; M Ito; T Le; L Audoly; C F Best; S Hiller; K Kluckman; N Maeda; O Smithies; T M Coffman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.

Authors:  F Niimura; P A Labosky; J Kakuchi; S Okubo; H Yoshida; T Oikawa; T Ichiki; A J Naftilan; A Fogo; T Inagami
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Renal impairment induced by prenatal exposure to angiotensin II in male rat offspring.

Authors:  Pavel Svitok; Monika Okuliarova; Ivan Varga; Michal Zeman
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-14

7.  Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.

Authors:  S Tsuchida; T Matsusaka; X Chen; S Okubo; F Niimura; H Nishimura; A Fogo; H Utsunomiya; T Inagami; I Ichikawa
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

8.  Implication of genetic variations in congenital obstructive nephropathy.

Authors:  Hyewon Hahn; So-Eun Ku; Kun-Suk Kim; Young-Seo Park; Chong-Hyun Yoon; Hae-Il Cheong
Journal:  Pediatr Nephrol       Date:  2005-08-25       Impact factor: 3.714

Review 9.  Renin-angiotensin system in ureteric bud branching morphogenesis: insights into the mechanisms.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

Review 10.  Developmental renal hemodynamics.

Authors:  L P Yao; P A Jose
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.